Healthcare Equipment and Supplies
Company Overview of Daktari Diagnostics, Inc.
Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.
85 Bolton Street
Cambridge, MA 02140
Founded in 2008
Key Executives for Daktari Diagnostics, Inc.
Chief Executive Officer, President and Director
Vice President of Finance
Vice President of Product Design and Development
Vice President of Quality & Regulatory
Vice President of Assay & R&D
Compensation as of Fiscal Year 2016.
Daktari Diagnostics, Inc. Key Developments
Daktari Diagnostics Appoints Donald B. Hawthorne as President & Chief Executive Officer and Member of the Board of Directors
Oct 28 15
Daktari Diagnostics announced the appointment of Donald B. Hawthorne as President & Chief Executive Officer (CEO), and member of the Board of Directors. Mr. Hawthorne brings over 30 years of life sciences industry experience, most recently as President & CEO of AdvanDx.
Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus
Aug 31 15
Daktari Diagnostics announced a collaboration with Merck, known as MSD outside the United States and Canada, to develop Daktari's rapid hepatitis C virus (HCV) screening test. The deal, worth up to $8.5 million over the next 3.5 years, will support an accelerated development timeline for the clinical validation and regulatory approval of Daktari's HCV test. The Daktari technology forms the basis for a point-of-care instrument that can detect low levels of virus directly in a single drop of blood in approximately 30 minutes, making on-the-spot HCV treatment decisions possible. The Daktari test is based on high-sensitivity measurement of the HCV core antigen, which is used in Europe and Japan for the diagnosis of chronic hepatitis C infection, but has never been available as a point-of-care diagnostic. The Daktari System includes an embedded connectivity platform, Daktari InSight, which provides real-time data management through mobile network connectivity and a web-based dashboard, allowing rapid monitoring of test results. The Daktari System has the potential to transform public health screening programs and be made available at retail clinics, pharmacies, and doctor's offices.
The National Institute of Health Awards Daktari Diagnostics with $1.2 Million Grant for Phase II Small Business Innovation Research
Mar 10 15
The National Institute of Health has awarded a Phase II Small Business Innovation Research (SBIR) grant to Daktari Diagnostics for development of a point-of-care hepatitis C diagnostic, following onto the Phase I grant awarded in June 2014 as part of the NIH SBIR Fast Track program. The Phase II grant, for $1.2 million, funds efforts in antibody science and microfluidics engineering to make the hepatitis C virus (HCV) viral load test fast and portable, enabling it to impact care in remote areas.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|